M&A Deal Summary

Dechra Pharmaceuticals Acquires DermaPet

On October 22, 2010, Dechra Pharmaceuticals acquired consumer services company DermaPet for 64M USD

Acquisition Highlights
  • This is Dechra Pharmaceuticals’ 1st transaction in the Consumer Services sector.
  • This is Dechra Pharmaceuticals’ 5th largest (disclosed) transaction.
  • This is Dechra Pharmaceuticals’ 1st transaction in the United States.
  • This is Dechra Pharmaceuticals’ 1st transaction in Maryland.

M&A Deal Summary
Date 2010-10-22
Target DermaPet
Sector Consumer Services
Buyer(s) Dechra Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 64M USD

Target

DermaPet

Potomac, Maryland, United States
DermaPet, Inc. develops and markets a range of dermatological preparations, including shampoos, conditioners and ear products, for the US and overseas companion animal markets. These veterinary products are marketed and distributed through the same channels as Dechra's current US product portfolio.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Dechra Pharmaceuticals

Northwich, United Kingdom
Category Company
Founded 1997
Sector Life Science
Revenue 682M GBP (2022)
DESCRIPTION

Dechra Pharmaceuticals is an international specialist in veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacturing, sales, and marketing of quality products exclusively for veterinarians worldwide. The company's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Dechra Pharmaceuticals was founded in 1997 and is based in Northwich, United Kingdom.

DEAL STATS #
Overall 4 of 16
Sector (Consumer Services) 1 of 1
Type (Add-on Acquisition) 4 of 14
State (Maryland) 1 of 1
Country (United States) 1 of 5
Year (2010) 1 of 2
Size (of disclosed) 5 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-12-07 Vetxx A/S

Uldum, Denmark

VetXX markets pharmaceutical products for skin, eye and ear diseases, produces pet diet food (through the brand SPECIFIC) and pet care products for companion animals. All animal health products are distributed exclusively through veterinary surgeries.

Buy £62M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-01 Genitrix

Billingshurst, United Kingdom

Genitrix Ltd. a veterinary pharmaceuticals company, offers veterinary care products for companion animals, such as dogs and cats, as well as for exotic pets, including rabbits, equines, guinea pigs, small rodents.

Buy £5M
Mergr

Product

Company

Legal